Edward M. Basile, Director at TransMedics Group, Inc. (TMDX), sold 8,286 shares at $125.51 ($1.0M) on 2025-08-04, disclosed to the SEC on 2025-08-05.
Scheduled sale ($1.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $125.51 | 4,143 | $520K | 50.0% |
| 2 | $125.51 | 4,143 | $520K | 50.0% |
| Total | $125.51 avg | 8,286 | $1.0M | 100% |
| Filing → |
| TMDX | SELL | 2025-05-13 | $694K | — | Filing → |
| TMDX | SELL | 2024-11-07 | $1.1M | — | Filing → |
| TMDX | SELL | 2024-08-08 | $1.9M | — | Filing → |